Teva (TEVA) volatility flat into Berkshire Hathaway (BRK.A) disclosed a stake in the company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Citi Remains Bullish on Teva Pharma (TEVA) Amid Buffett Stake
February 15, 2018 7:18 AM ESTCiti reiterated a Buy rating and $24.00 price target on Teva Pharma (NYSE: TEVA) following the company's 13-F filing. Berkshire Hathaway reported a new stake of 18.9mn shares in TEVA, representing a total investment of ~$360mn at current levels.
Analyst Liav Abraham... More
